Table 1. Characteristics of the asthma patients and control group.
| Asthma patients (n = 50) | Control group (n = 57) | p-value | |
| Gender, female/male | 24/26 | 34/23 | > 0.05 |
| Age, years | 11.7 ± 2.7 | 12.3 ± 2.8 | > 0.05 |
| Presence of atopy, % | 37 (74) | 0 (0) | |
| Immunotherapy | 27 (54) | 0 (0) | |
| Duration of diagnosis of asthma, years | 8.1 ± 2.8 (3–15) | ||
| Weight, kg | 43.0 ± 15.5 | 47.8 ± 17.0 | > 0.05 |
| Height, cm | 148.0 ± 15.9 | 150.4 ± 16.1 | > 0.05 |
| BMI, kg/m² | 19.0 ± 4.1 | 20.5 ± 4.3 | > 0.05 |
| Systolic blood pressure, mmHg | 101.1 ± 10.4 | 102.4 ± 10.4 | > 0.05 |
| Diastolic blood pressure, mmHg | 63.5 ± 9.9 | 64.9 ± 9.8 | > 0.05 |
| Mean blood pressure, mmHg | 76.0 ± 9.2 | 77.4 ± 9.3 | > 0.05 |
| Heart rate, beat/min | 84 ± 15 | 85 ± 14 | > 0.05 |
| Total cholesterol, mg/dl (mmol/l) | 152.5 ± 32.6 (3.96 ± 0.84) | 147.5 ± 24.6 (3.82 ± 0.64) | > 0.05 |
| LDL cholesterol, mg/dl (mmol/l) | 83.6 ± 17.8 (2.17 ± 0.46) | 79.6 ± 18.1 (2.06 ± 0.47) | > 0.05 |
| HDL cholesterol, mg/dl (mmol/l) | 55.6 ± 17.3 (1.44 ± 0.45) | 50.7 ± 11.5 (1.31 ± 0.30) | > 0.05 |
| hs-CRP, mg/dl | 2.12 ± 0.41 | 0.79 ± 0.20 | < 0.05 |
| FVC, % predicted | 87.3 ± 13.6 | 87.1 ± 10.6 | > 0.05 |
| FEV1, % predicted | 97.7 ± 14.9 | 99.2 ± 11.1 | > 0.05 |
| FEV1/FVC, % | 95.2 ± 5.8 | 97.0 ± 4.3 | > 0.05 |
| PEF, % predicted | 92.8 ± 16.6 | 89.8 ± 14.6 | > 0.05 |
Data are presented as mean ± standard deviation.
BMI: body mass index, FEV1: forced expiratory volume in one second, FVC: forced vital capacity, HDL: high-density lipoprotein, LDL: low-density lipoprotein, PEF: peak expiratory flow.